Internal Medicine · Charlotte, NC
NPI
1265451918
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1350 S Kings Dr
Charlotte, NC, 28207
Phone (704) 446-1242
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
7,140 services
Medicare patients, 2024
76
Average age 62
Drug cost, 2024
$12.6M
5,563 prescriptions
Company payments, 2025
$64K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc A Johnson was code 99214 (office e&m - established), 95 times for 61 patients. In total Marc A Johnson billed 7,140 services in 30 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 95 | 61 | $72.90 | $6,925 |
By year: 2022 $30K for 840 services; 2023 $28K for 11,616 services; 2024 $16K for 7,140 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc A Johnson prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 1,217 prescriptions and refills. In total Marc A Johnson wrote 5,563 Medicare prescriptions that cost $12.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 1,217 | 1,217 | 126 | $5.0M |
| Dovato Dolutegravir Sodium/Lamivudine | 685 | 687 | 77 | $2.1M |
| Tivicay Dolutegravir Sodium | 379 | 381 | 50 | $877K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 242 | 244 | 32 | $1.2M |
| Amlodipine Besylate Generic | 218 | 354 | 41 | $867 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 209 | 209 | 23 | $850K |
| Juluca Dolutegravir/Rilpivirine | 197 | 197 | 22 | $690K |
| Descovy Emtricitabine/Tenofov Alafenam | 157 | 157 | 19 | $350K |
| Atorvastatin Calcium Generic | 154 | 246 | 35 | $622 |
| Lisinopril Generic | 115 | 185 | 21 | $352 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 112 | 112 | 12 | $396K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 104 | 104 | 15 | $385K |
| Omeprazole Generic | 88 | 128 | 16 | $895 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 78 | 90 | 16 | $692 |
| Prezcobix Darunavir/Cobicistat | 75 | 75 | Under 11 | $176K |
Brand drugs: 3,604 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc A Johnson $64K ($64K in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $47K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.